Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac preload describes the degree of stretch or initial tension in myocardial fibers caused by ventricular filling at the end of diastole, just before contraction. It is a determinant of stroke volume according to the Frank-Starling law: the greater the stretch (within physiological limits), the stronger the subsequent contraction. Preload is affected by blood volume, venous return, heart rate, rhythm, and ventricular compliance. Clinically, it is estimated by ventricular end-diastolic pressure or volume. Preload manipulation is important in managing fluid balance, heart failure, and shock, but it is not a discrete molecular or receptor target for drugs.
Drugs that reduce preload generally decrease blood volume (diuretics), increase venous dilation (nitrates), or alter cardiac filling pressures; Drugs that increase preload may include fluids/blood products
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac preload.